Epilepsy Trial, Recruiting NCT06248333 Sponsor: Xuanwu Hospital, Beijing Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT06248333
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 14 and 65 years old (inclusive) at the time of your screening visit.
  • Your seizures have not been controlled well enough by anti-seizure medications.
  • You have been diagnosed with a type of epilepsy where seizures start in a specific area of the brain and mainly involve movement or sensation, and doctors have identified that the seizure-causing area is likely in or around the motor or sensory regions of the brain.
  • In the month before your screening visit, you had at least 3 seizures of this type, and you have been on a stable anti-seizure medication routine (no medicines added or removed, though dose changes are allowed).
  • During the 3-month baseline period after your screening visit, you or your caregiver can keep a daily seizure diary, you continue to have an average of 3 or more of these seizures per month (with no gap of more than 30 days between seizures), and your medication routine stays stable.
  • After a full medical evaluation before any procedure, doctors have decided that traditional surgery to remove the seizure-causing area is not suitable for you, you have chosen not to have that surgery, or a previous surgical procedure did not work well enough.
  • You are willing and able to give written informed consent to participate.

Who may not be able to join:

  • You have been diagnosed with a type of epilepsy that affects the whole brain or is caused by an inherited gene mutation affecting ion channels.
  • Your seizures mainly involve complex movements such as repetitive automatic behaviours or very fast, exaggerated movements.
  • You have had a prolonged, continuous tonic-clonic seizure (status epilepticus) within the last 12 months.
  • You have had seizures that were found to be psychological rather than neurological in origin within the last 12 months.
  • You have a structural problem or damage in a specific deep brain region called the subthalamic nucleus.
  • You already have an electrical stimulation device implanted anywhere in your body (such as a heart pacemaker or spinal cord stimulator), or you have any metal implants in your head (such as aneurysm clips or cochlear implants) — note that a vagal nerve stimulator may be allowed if its settings have been stable for at least 3 months before screening (confirm with trial site).
  • You have a condition that increases your risk of bleeding during or after surgery, or you need to take blood-thinning or anti-clotting medications regularly.
  • You have an IQ below 55 or severe difficulties with thinking and memory that would prevent you from completing the study.
  • You have a neurological condition that is getting progressively worse over time (such as Rasmussen's encephalitis).
  • You have been diagnosed with a serious mental health condition such as dementia, severe depression (including any history of suicidal or self-harming thoughts, or a psychiatric hospital admission within the last 5 years), schizophrenia, or a brain-degenerative disorder.
  • You have another serious physical illness or significantly reduced liver or kidney function.
  • You are pregnant or planning to become pregnant within the next 2 years.
  • You have taken part in another clinical trial within the last 3 months.
  • The medical team at the trial centre has assessed that you are not suitable for enrolment for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Liankun Ren, MD, Xuanwu Hospital, Beijing

Phone: +86 13681576621

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Xuanwu Hospital, Beijing
Registry
ClinicalTrials.gov
Start date
14 February 2024
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Median Percent Change in Seizure Frequency

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov